{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:53:14Z","timestamp":1784375594708,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012334","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000}}],"reference-count":125,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012334.pub2","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T07:37:15Z","timestamp":1560757035000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis"],"prefix":"10.1002","author":[{"given":"Harry D","family":"Zacharias","sequence":"first","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony P","family":"Zacharias","sequence":"additional","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kettegaards Alle 30 Hvidovre Denmark 2650"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha Y","family":"Morgan","sequence":"additional","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/S0168-8278(13)60192-0","article-title":"AST-120 (spherical carbon adsorbent) in covert hepatic encephalopathy: results of the Astute trial","volume":"58","author":"Bajaj","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"5 (Suppl 1)","key":"10.1002\/14651858.CD012334.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S997","DOI":"10.1016\/S0016-5085(13)63702-6","article-title":"Su1685 AST-120 (spherical carbon adsorbent) in covert hepatic encephalopathy: results of the Astute trial","volume":"144","author":"Bajaj","year":"2013","journal-title":"Gastroenterology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012334.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"67I","DOI":"10.1016\/0270-9139(94)90438-3","article-title":"Treatment of acute portal systemic encephalopathy (PSE) grades III and IV with sodium benzoate and lactose","volume":"19","author":"Gonzalez","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/mejdd.2016.46","article-title":"Polyethylene glycol and lactulose alone in the treatment of hepatic encephalopathy in patients with cirrhosis: a non-inferiority randomised control trial","volume":"9","author":"Naderian","year":"2017","journal-title":"Middle East Journal of DIgestive Diseases"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Pockros P Hassanein T Vierling J Heuman D Hillebrand D Chojkier M Phase 2, multicenter, randomised study of AST-120 (spherical carbon adsorbent) vs. lactulose in the treatment of low-grade hepatic encephalopathy (HE) Journal of Hepatology 2009 S43","DOI":"10.1016\/S0168-8278(09)60107-0"},{"issue":"11","key":"10.1002\/14651858.CD012334.pub2-BIB0006|cit6","first-page":"1727","article-title":"Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomised clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"Journal of the American Medical Association Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD012334.pub2-BIB0007|cit7","first-page":"915A","article-title":"A randomised trial of polyethylene glycol 3350-electrolyte solution (PEG) and lactulose for patients hospitalized with acute hepatic encephalopathy","volume":"56","author":"Rahimi","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40290-015-0134-2","article-title":"Variation in liver biochemistries in patients with decompensated cirrhosis: implications for assessing drug-induced liver injury in clinical trials","volume":"30","author":"Jurek","year":"2016","journal-title":"Pharmaceutical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep.26611","article-title":"Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy","volume":"59","author":"Rockey","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1002\/14651858.CD012334.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1097\/MEG.0000000000001267","article-title":"Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy","volume":"30","author":"Shehata","year":"2018","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0011|cit11","first-page":"276A","article-title":"STOP-HE: a randomised, double-blind, placebo-controlled study of OCR-002 in patients with hepatic encephalopathy","volume":"66","author":"Rahimi","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0012|cit12","first-page":"126A","article-title":"OCR-002 (ornithine phenylacetate) is a potent ammonia scavenger as demonstrated in phase 2b STOP-HE study","volume":"66","author":"Safadi","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0013|cit13","first-page":"274A","article-title":"Geographic differences for patients enrolled in STOP-HE: a randomised, phase 2 study of OCR-002 for hepatic encephalopathy","volume":"66","author":"Thabut","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.1840160123","article-title":"Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomised trial","volume":"16","author":"Sushma","year":"1992","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl","key":"10.1002\/14651858.CD012334.pub2-BIB0015|cit15","first-page":"149","article-title":"Sodium benzoate in portalsystemic encephalopathy induced blood ammonia normalization and clinical improvement. Interim report of a double blind multicenter trial","volume":"42","author":"Uribe","year":"1990","journal-title":"Revista de Investigaci\u00f3n Cl\u00ednica"},{"issue":"10","key":"10.1002\/14651858.CD012334.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/MCG.0b013e318299c789","article-title":"Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study","volume":"47","author":"Ventura-Cots","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1756283X16658252","article-title":"Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients","volume":"9","author":"Ventura-Cots","year":"2016","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0018|cit18","first-page":"248A","article-title":"Efficacy and safety of sodium benzoate for the long-term treatment of chronic hyperammonemic hepatic encephalopathy","volume":"16","author":"Campollo","year":"1992","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cpdd.18","article-title":"Glycerol phenylbutyrate in patients with cirrhosis and episodic hepatic encephalopathy: a pilot study of safety and effect on venous ammonia concentration","volume":"2","author":"Ghabril","year":"2013","journal-title":"Clinical Pharmacology in Drug Development"},{"issue":"7","key":"10.1002\/14651858.CD012334.pub2-BIB0020|cit20","first-page":"540","article-title":"A new therapy for portal systemic encephalopathy","volume":"81","author":"Mendenhall","year":"1986","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0021|cit21","first-page":"228","article-title":"Oral Na-benzoate in the treatment of chronic hepatic encephalopathy","volume":"25","author":"Panella","year":"1993","journal-title":"Italian Journal of Gastroenterology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012334.pub2-BIB0022|cit22","first-page":"S43","article-title":"Oral sodium benzoate in the treatment of chronic hepatic encephalopathy","volume":"34","author":"Panella","year":"1993","journal-title":"Gut"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD012334.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1016\/S0168-8278(16)00355-X","article-title":"Sodium phenylbutyrate administration to avoid neurological worsening in cirrhotic patients with hepatic encephalopathy admitted in ICU","volume":"64","author":"Tripon","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/fcp.12340","article-title":"Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study","volume":"32","author":"Weiss","year":"2018","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0025|cit25","unstructured":"NCT00558038 Safety and efficacy of AST-120 compared to lactulose in patients with hepatic encephalopathy (AST015) clinicaltrials.gov\/ct2\/show\/NCT00558038"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0026|cit26","unstructured":"NCT03448770 To compare efficacy and safety of lactulose versus polyethylene glycol for treatment of overt hepatic encephalopathy in cirrhotics: a randomised controlled trial clinicaltrials.gov\/ct2\/show\/nct03448770"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","author":"American Association for the Study of Liver Diseases","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD012334.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41395-018-0179-4","article-title":"Current management of hepatic encephalopathy","volume":"113","author":"Acharya","year":"2018","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1665-2681(19)30880-4","article-title":"Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy?","volume":"13","author":"Ahuja","year":"2014","journal-title":"Annals of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2015.377","article-title":"Diagnosis of minimal hepatic encephalopathy using strop EncephalApp: a multicentre US-based, norm-based study","volume":"111","author":"Allampati","year":"2016","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","article-title":"Inhibitory control test for the diagnosis of minimal hepatic encephalopathy","volume":"135","author":"Bajaj","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7","key":"10.1002\/14651858.CD012334.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012334.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD012334.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD012334.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1746-6342.2006.03218.x","article-title":"Review article: the current pharmacological therapies for hepatic encephalopathy","volume":"25","author":"Bass","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2014.02.007","article-title":"Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes","volume":"112","author":"Berry","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012334.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1665-2681(19)31609-6","article-title":"Determination of ammonia concentrations in cirrhosis patients - still confusing after all these years?","volume":"10","author":"Blanco Vela","year":"2011","journal-title":"Annals of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.24273","article-title":"AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats","volume":"53","author":"Bosoi","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7572","key":"10.1002\/14651858.CD012334.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research recommendations","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-8278(00)80424-9","article-title":"Complications of cirrhosis III. Hepatic encephalopathy","volume":"32","author":"Butterworth","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD012334.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","article-title":"The liver-brain axis in liver failure: neuroinflammation and encephalopathy","volume":"10","author":"Butterworth","year":"2013","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1572-0241.2001.03552.x","article-title":"Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?","volume":"96","author":"Cadranel","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl","key":"10.1002\/14651858.CD012334.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1111\/j.1440-1746.1997.tb00512.x","article-title":"Evoked potentials in liver diseases","volume":"12","author":"Chu","year":"1997","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD012334.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","article-title":"Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver","volume":"103","author":"Jongh","year":"1992","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012334.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17425255.2017.1262843","article-title":"An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease","volume":"13","author":"Las Heras","year":"2017","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0049|cit49","unstructured":"Deeks JJ Higgins JP Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1440-1746.1995.tb01041.x","article-title":"Figure connection test: a universal test for assessment of mental state","volume":"10","author":"Dhiman","year":"1995","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01320309","article-title":"Survival and prognostic indicators in compensated and decompensated cirrhosis","volume":"31","author":"D\u2019Amico","year":"1986","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD012334.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1111\/j.1572-0241.2000.03295.x","article-title":"Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution","volume":"95","author":"Efrati","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"7109","key":"10.1002\/14651858.CD012334.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"CD003044","DOI":"10.1002\/14651858.CD003044.pub4","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"5","author":"Gluud","year":"2016","journal-title":"Cochrane Database Systematic Review"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012410.pub2","article-title":"L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis","author":"Goh","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0058|cit58","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro 2015"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1478-3231.2009.02030.x","article-title":"Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Gu\u00e9rit","year":"2009","journal-title":"Liver International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12072-017-9812-3","article-title":"Hepatic encephalopathy: a critical current review","volume":"12","author":"Hadjihambi","year":"2018","journal-title":"Hepatology International"},{"issue":"20","key":"10.1002\/14651858.CD012334.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10620-007-9895-0","article-title":"Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)","volume":"53","author":"Hassanein","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(00)80110-5","article-title":"Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?","volume":"32","author":"Haussinger","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0066|cit66","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0067|cit67","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0068|cit68","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"8","key":"10.1002\/14651858.CD012334.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/j.clinph.2016.03.027","article-title":"New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy","volume":"127","author":"Jackson","year":"2016","journal-title":"Clinical Neurophysiology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.mehy.2006.12.061","article-title":"L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy","volume":"69","author":"Jalan","year":"2007","journal-title":"Medical Hypotheses"},{"issue":"7","key":"10.1002\/14651858.CD012334.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/1060028016645826","article-title":"Management of hepatic encephalopathy","volume":"50","author":"Jawaro","year":"2016","journal-title":"Annals of Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"The clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11011-013-9391-5","article-title":"Ornithine phenylacetate revisited","volume":"28","author":"Jover-Cobos","year":"2013","journal-title":"Metabolic Brain Disease"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/jhep.2002.30957","article-title":"Critical flicker frequency for quantification of low-grade hepatic encephalopathy","volume":"35","author":"Kircheis","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2009.08.003","article-title":"Hepatic encephalopathy and fitness to drive","volume":"137","author":"Kircheis","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11894-018-0627-8","article-title":"Update on the therapeutic management of hepatic encephalopathy","volume":"20","author":"Kornerup","year":"2018","journal-title":"Current Gastroenterology Reports"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11011-011-9242-1","article-title":"Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease","volume":"26","author":"Lauridsen","year":"2011","journal-title":"Metabolic Brain Disease"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2010.03.014","article-title":"Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control","volume":"100","author":"Lee","year":"2010","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3-4","key":"10.1002\/14651858.CD012334.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:MEBR.0000043980.74574.eb","article-title":"Blood ammonia levels and hepatic encephalopathy","volume":"19","author":"Lockwood","year":"2004","journal-title":"Metabolic Brain Disease"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2008.06.043","article-title":"Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant","volume":"135","author":"Mardini","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2015.04.009","article-title":"Recent advances in the treatment of hyperammonemia","volume":"90","author":"Matoori","year":"2015","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23589","article-title":"Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis","volume":"51","author":"McGuire","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0083|cit83","unstructured":"Higgins JP Lasserson T Chandler J Tovey D Churchill R Methodological expectations of Cochrane intervention reviews - Version 1.07 community.cochrane.org\/mecir-manual"},{"issue":"4","key":"10.1002\/14651858.CD012334.pub2-BIB0084|cit84","first-page":"219","article-title":"Sodium benzoate for treatment of hepatic encephalopathy","volume":"9","author":"Misel","year":"2013","journal-title":"Gastroenterology & Hepatology"},{"issue":"3-4","key":"10.1002\/14651858.CD012334.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/B:MEBR.0000043977.11113.2a","article-title":"Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach","volume":"19","author":"Montagnese","year":"2004","journal-title":"Metabolic Brain Disease"},{"issue":"42","key":"10.1002\/14651858.CD012334.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"15756","DOI":"10.3748\/wjg.v20.i42.15756","article-title":"Covert hepatic encephalopathy: agreement and predictive validity of different indices","volume":"20","author":"Montagnese","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"Chapter 10: pp","DOI":"10.1002\/9781119237662.ch10","article-title":"Hepatic encephalopathy","volume-title":"Sherlock's Diseases of the Liver and Biliary System","author":"Morgan","year":"2018"},{"issue":"8752","key":"10.1002\/14651858.CD012334.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0140-6736(91)92920-W","article-title":"Regional cerebral blood flow and cognitive function in patients with chronic liver disease","volume":"337","author":"O'Carroll","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jhep.2016.05.004","article-title":"Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy","volume":"65","author":"Olesen","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1365-2036.2007.03394.x","article-title":"Development of a clinical hepatic encephalopathy staging scale","volume":"26","author":"Ortiz","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD012334.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000035.pub2","article-title":"Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions","author":"Page","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012334.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s10620-017-4630-y","article-title":"A new look at precipitants of overt hepatic encephalopathy in cirrhosis","volume":"62","author":"Pantham","year":"2017","journal-title":"Digestive Diseases and Sciences"},{"issue":"7001","key":"10.1002\/14651858.CD012334.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(57)90005-3","article-title":"The electroencephalograph in liver disease","volume":"270","author":"Parsons-Smith","year":"1957","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012334.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","article-title":"Review article: the burden of hepatic encephalopathy","volume":"25","author":"Poodad","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0036-1571298","article-title":"Hepatic encephalopathy: pharmacological therapies targeting ammonia","volume":"36","author":"Rahimi","year":"2016","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0096|cit96","volume-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)","author":"Randolph","year":"1998"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","article-title":"Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Randolph","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0098|cit98","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls","volume":"106","author":"Roman","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012334.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2012.112","article-title":"Ammonia-lowering strategies for the treatment of hepatic encephalopathy","volume":"92","author":"Rose","year":"2012","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomised controlled trials used in Cochrane Reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"6260","key":"10.1002\/14651858.CD012334.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmj.282.6260.263","article-title":"A 20-year prospective study of cirrhosis","volume":"282","author":"Saunders","year":"1981","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"35","key":"10.1002\/14651858.CD012334.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD012334.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012334.pub2-BIB0105|cit105","first-page":"522","article-title":"Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive","volume":"26","author":"Schomerus","year":"1981","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD012334.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1020645110880","article-title":"Neuropsychological aspects of portal-systemic encephalopathy","volume":"13","author":"Schomerus","year":"1998","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0107|cit107","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach gdt.gradepro.org\/app\/handbook\/handbook.html"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MEG.0b013e3283341b7d","article-title":"Predictors of non response to lactulose in patients with cirrhosis and hepatic encephalopathy","volume":"22","author":"Sharma","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.21593","article-title":"Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation","volume":"15","author":"Sotil","year":"2009","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD012334.pub2-BIB0110|cit110","unstructured":"Stata Corp Stata: Release 14 2015"},{"issue":"9","key":"10.1002\/14651858.CD012334.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cgh.2012.05.016","article-title":"In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD012334.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/17474124.2014.858598","article-title":"Recent insights into the pathogenesis of hepatic encephalopathy and treatments","volume":"8","author":"Sturgeon","year":"2014","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012334.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02098881","article-title":"Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy","volume":"9","author":"Taylor-Robinson","year":"1994","journal-title":"Metabolic Brain Disease"},{"issue":"7872","key":"10.1002\/14651858.CD012334.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"304","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"RA53","DOI":"10.12659\/MSM.881387","article-title":"Hepatic encephalopathy: an updated approach from pathogenesis to treatment","volume":"17","author":"Toris","year":"2011","journal-title":"Medical Science Monitor"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-196509000-00001","article-title":"The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration","volume":"44","author":"Victor","year":"1965","journal-title":"Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012334.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000051415","article-title":"Diagnosis of encephalopathy","volume":"59","author":"Weissenborn","year":"1998","journal-title":"Digestion"},{"issue":"5","key":"10.1002\/14651858.CD012334.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012334.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1478-3231.2010.02302.x","article-title":"Interorgan ammonia metabolism in liver failure: the basis of current and future therapies","volume":"31","author":"Wright","year":"2011","journal-title":"Liver International"},{"issue":"1","key":"10.1002\/14651858.CD012334.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/apt.13830","article-title":"Stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfalls","volume":"45","author":"Zacharias","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD012334.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver International"},{"issue":"8","key":"10.1002\/14651858.CD012334.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012334","article-title":"Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy","author":"Zacharias","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012334.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:05:48Z","timestamp":1628535948000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012334.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":125,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012334.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736004969.793573495","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]}}}